CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating expenses:
Research and development	$ 93,310	$ 94,315
General and administrative	27,875	31,721
Total operating expenses	121,185	126,036
Loss from operations	(121,185)	(126,036)
Other income:
Interest income	4,271	8,173
Total other income	4,271	8,173
Net loss	$ (116,914)	$ (117,863)
Net loss per share, basic	$ (1.70)	$ (1.75)
Net loss per share, diluted	$ (1.70)	$ (1.75)
Weighted-average common shares outstanding, basic	68,705,639	67,191,973
Weighted-average common shares outstanding, diluted	68,705,639	67,191,973
Other comprehensive income
Unrealized gain on available for sale marketable securities	$ 99	$ 693
Total other comprehensive income	99	693
Comprehensive loss	$ (116,815)	$ (117,170)